Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04393649

First Level Socio-geriatric Evaluation: ESOGER Databank

First Level Socio-geriatric Evaluation in Period of Physical and Social Distancing in Frail Older Patients and Older Community Dwellers: ESOGER Databank

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
20,000 (actual)
Sponsor
Jewish General Hospital · Academic / Other
Sex
All
Age
70 Years
Healthy volunteers

Summary

Coronavirus disease 2019 (COVID-19) is an infectious disease. Physical distancing is one of the most effective ways to reduce the spread of COVID-19, but this key prevention intervention may have adverse consequences on older adults living at home. Screening older adults living at home and at risk for adverse consequences of physical and social distancing is, therefore, a priority in order to prevent their occurrence. ESOGER ("Evaluation Social et GERiatrique") is a clinical tool designed to: 1) screen the risk-levels for adverse consequences related to COVID-19 physical distancing and 2) to continue appropriate preventive interventions in older adults living at home including frail older patients and older community dwellers. Experience cumulated during the past two weeks revealed that ESOGER could be improved, in order to be more effective and efficient for the prevention of adverse consequences related to COVID-19 physical distancing. This improvement is based on two key components: 1) Comments of Montreal ESOGER users and 2) Analysis of data. Because at this time no information is saved and stored, there is a need to save and store ESOGER information and create the ESOGER databank.

Conditions

Interventions

TypeNameDescription
OTHERESOGERQuestionnaire

Timeline

Start date
2020-04-20
Primary completion
2027-04-19
Completion
2027-04-19
First posted
2020-05-19
Last updated
2024-02-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04393649. Inclusion in this directory is not an endorsement.